Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 142-148, January 1, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crowe, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crowe, D. L.

Retinoic Acid Receptor ß Induces Terminal Differentiation of Squamous Cell Carcinoma Lines in the Absence of Cyclin-dependent Kinase Inhibitor Expression1

David L. Crowe2

Center for Craniofacial Molecular Biology, University of Southern California, Los Angeles, California 90033

The chemotherapeutic agent and vitamin A metabolite retinoic acid (RA) has been used to treat many tumor types. The effects of RA are mediated by a family of ligand-dependent transcription factors, the retinoic acid receptors (RAR) and the retinoid X receptors. Alterations in RAR expression have been implicated in tumorigenesis. We showed previously that loss of RARß expression and target gene responsiveness to RA were consistent features of head and neck squamous cell carcinoma lines. To begin to elucidate the role of RARß in the malignant transformation of stratified squamous epithelia, we reexpressed RARß in squamous cell carcinoma (SCC) lines by stable transfection. SCC lines expressing RARß produced large numbers of flat cells with abundant cytoplasm that died and detached from the culture dish. These cells morphologically resembled the differentiated cells of normal stratified squamous epithelium in culture. These cells did not exhibit the characteristic DNA fragmentation pattern of apoptotic cells, nor did they label in a fluorescent apoptosis assay. Northern and Western blotting revealed induction of terminal differentiation markers in these cells. RARß produced alterations in levels of RA-responsive gene expression in these cells, and terminal differentiation occurred in the absence of detectable cyclin-dependent kinase inhibitor expression. We concluded that RARß expression induced terminal differentiation in SCC lines, suggesting a role for this transcription factor in the normal maturation of stratified squamous epithelium.

1 This study was supported by NIH Grant DE10966.

2 To whom requests for reprints should be addressed, at Center for Craniofacial Molecular Biology, University of Southern California, 2250 Alcazar Street, CSA 103, Los Angeles, CA 90033. Phone: (213) 342-3170; Fax: (213) 342-2981.

Received 5/23/97. Accepted 10/29/97.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
D. L. Crowe, R. Kim, and R. A.S. Chandraratna
Retinoic Acid Differentially Regulates Cancer Cell Proliferation via Dose-Dependent Modulation of the Mitogen-Activated Protein Kinase Pathway
Mol. Cancer Res., May 1, 2003; 1(7): 532 - 540.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. I. Chen, K. M. Sommer, and K. Swisshelm
Downstream Codons in the Retinoic Acid Receptor beta -2 and beta -4 mRNAs Initiate Translation of a Protein Isoform That Disrupts Retinoid-activated Transcription
J. Biol. Chem., September 13, 2002; 277(38): 35411 - 35421.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. S. Angelo, M. Talpaz, and R. Kurzrock
Autocrine Interleukin-6 Production in Renal Cell Carcinoma: Evidence for the Involvement of p53
Cancer Res., February 1, 2002; 62(3): 932 - 940.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
N. Akutsu, R. Lin, Y. Bastien, A. Bestawros, D. J. Enepekides, M. J. Black, and J. H. White
Regulation of Gene Expression by 1{{alpha}},25-Dihydroxyvitamin D3 and Its Analog EB1089 under Growth-Inhibitory Conditions in Squamous Carcinoma Cells
Mol. Endocrinol., July 1, 2001; 15(7): 1127 - 1139.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Wan, N. Oridate, D. Lotan, W. K. Hong, and R. Lotan
Overexpression of Retinoic Acid Receptor {beta} in Head and Neck Squamous Cell Carcinoma Cells Increases Their Sensitivity to Retinoid-induced Suppression of Squamous Differentiation by Retinoids
Cancer Res., July 1, 1999; 59(14): 3518 - 3526.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
E. Picard, C. Seguin, N. Monhoven, C. Rochette-Egly, J. Siat, J. Borrelly, Y. Martinet, N. Martinet, and J. M. Vignaud
Expression of Retinoid Receptor Genes and Proteins in Non-Small-Cell Lung Cancer
J Natl Cancer Inst, June 16, 1999; 91(12): 1059 - 1066.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.